Evolent Health Operating Margin 2014-2025 | EVH
Current and historical operating margin for Evolent Health (EVH) over the last 10 years. The current operating profit margin for Evolent Health as of June 30, 2025 is 0.81%.
| Evolent Health Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $2.20B | $-0.04B | -1.73% |
| 2025-03-31 | $2.40B | $-0.03B | -1.21% |
| 2024-12-31 | $2.56B | $-0.04B | -1.57% |
| 2024-09-30 | $2.46B | $-0.04B | -1.70% |
| 2024-06-30 | $2.35B | $-0.04B | -1.87% |
| 2024-03-31 | $2.18B | $-0.07B | -3.40% |
| 2023-12-31 | $1.96B | $-0.07B | -3.62% |
| 2023-09-30 | $1.79B | $-0.05B | -2.91% |
| 2023-06-30 | $1.63B | $-0.02B | -1.29% |
| 2023-03-31 | $1.48B | $0.00B | -0.27% |
| 2022-12-31 | $1.35B | $0.00B | 0.22% |
| 2022-09-30 | $1.22B | $-0.01B | -0.57% |
| 2022-06-30 | $1.09B | $-0.03B | -2.48% |
| 2022-03-31 | $0.99B | $-0.03B | -3.03% |
| 2021-12-31 | $0.91B | $-0.04B | -4.74% |
| 2021-09-30 | $0.91B | $-0.03B | -2.87% |
| 2021-06-30 | $0.92B | $-0.04B | -3.79% |
| 2021-03-31 | $0.92B | $-0.25B | -27.53% |
| 2020-12-31 | $0.93B | $-0.26B | -28.32% |
| 2020-09-30 | $0.76B | $-0.48B | -64.11% |
| 2020-06-30 | $0.74B | $-0.49B | -66.39% |
| 2020-03-31 | $0.71B | $-0.29B | -40.42% |
| 2019-12-31 | $0.69B | $-0.31B | -44.98% |
| 2019-09-30 | $0.80B | $-0.11B | -13.08% |
| 2019-06-30 | $0.73B | $-0.10B | -13.10% |
| 2019-03-31 | $0.69B | $-0.08B | -11.68% |
| 2018-12-31 | $0.63B | $-0.05B | -7.50% |
| 2018-09-30 | $0.55B | $-0.05B | -9.49% |
| 2018-06-30 | $0.51B | $-0.06B | -10.87% |
| 2018-03-31 | $0.47B | $-0.07B | -13.86% |
| 2017-12-31 | $0.44B | $-0.07B | -16.55% |
| 2017-09-30 | $0.41B | $-0.09B | -21.52% |
| 2017-06-30 | $0.36B | $-0.09B | -24.93% |
| 2017-03-31 | $0.31B | $-0.08B | -27.01% |
| 2016-12-31 | $0.25B | $-0.24B | -93.70% |
| 2016-09-30 | $0.21B | $-0.22B | -102.83% |
| 2016-06-30 | $0.19B | $-0.22B | -114.06% |
| 2016-03-31 | $0.15B | $-0.22B | -150.34% |
| 2015-09-30 | $0.03B | $-0.02B | -56.67% |
| 2014-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.140B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Phreesia (PHR) | United States | $1.808B | 0.00 |
| Enovis (ENOV) | United States | $1.771B | 9.36 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.474B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |